Shiwei Wang
Shiwei Wang
Contributor, The Yuan

Shiwei Wang is founder of Evomics Medical - an artificial intelligence-based healthcare startup pursuing an unprecedentedly holistic approach to precision medicine - and publisher of The Yuan. With a PhD from Peking University, he is former Head of Investment at ShangPharma in Greater China, a partner at ShangPharma Capital and Raymoon Capital, an investor in Aprinoia, Elixiron, YL Pharma, and Appotronics, and was co-founder and CFO at Maxinovel.

The Yuan AI 2023: AI to drive future nuclear medicine
The Yuan AI 2023
The Yuan is embarking on its second annual series on the course of AI in the coming year after the stellar success of the inaugural 2022 event. As ever, The Yuan is following our lodestone of all-inclusive, representative, safe, and transparent AI to pilot this nascent transformative technology through storms and uncharted reefs and guide it into a safe haven for the benefit of all. Shiwei Wang, founder of AI-based holistic healthcare startup Evomics Medical, peers into his futurescope to divine AI’s development in the new year 2023 to launch this year’s series.
Shiwei Wang  |  Dec 21, 2022